Publications by authors named "Edwin A Basak"

Claim this Profile
R
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
Karlijn de Joode, Niels Heersche, Edwin A Basak, Sander Bins, Astrid A M van der Veldt

Cancer Treat Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy.
Edwin A Basak, Karlijn de Joode, Tom J J Uyl, Ronald van der Wal, Marco W J Schreurs

Biomed Pharmacother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Edwin A Basak, Niels S Vermeer, Karlijn de Joode, Daan P Hurkmans, Dorian E M Velthuis

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.
Daan P Hurkmans, Sebastiaan D T Sassen, Karlijn de Joode, Lisanne Putter, Edwin A Basak

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
Daan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, Rik de Wijn, Lies Hovestad, Edwin A Basak

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.
Edwin A Basak, Jan W M van der Meer, Daan P Hurkmans, Marco W J Schreurs, Esther Oomen-de Hoop

Thyroid· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.
Daan P Hurkmans, Edwin A Basak, Nina Schepers, Esther Oomen-De Hoop, Cor H Van der Leest

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.
Daan P Hurkmans, Edwin A Basak, Tanja van Dijk, Darlene Mercieca, Marco W J Schreurs

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD45RACCR7 CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
Andre Kunert, Edwin A Basak, Daan P Hurkmans, Hayri E Balcioglu, Yarne Klaver

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.
Edwin A Basak, Stijn L W Koolen, Daan P Hurkmans, Marco W J Schreurs, Sander Bins

Eur J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum Concentrations.
Edwin A Basak, Annemarie J M Wijkhuijs, Ron H J Mathijssen, Stijn L W Koolen, Marco W J Schreurs

Ther Drug Monit· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Sander Bins, Edwin A Basak, Samira El Bouazzaoui, Stijn L W Koolen, E Oomen-de Hoop

Br J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis